| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ICAD INC | CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 150K | $936K | $6.24 | Jan 10, 2022 | Direct |
| CERO THERAPEUTICS HOLDINGS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 100K | Jun 28, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | Jun 28, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Chief Financial Officer |
| CERO | CERO THERAPEUTICS HOLDINGS, INC. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Chief Financial Officer |
| CERO | PHOENIX BIOTECH ACQUISITION CORP. | Feb 14, 2024 | 0 | $0 | 3 | Feb 16, 2024 | Chief Financial Officer |
| ICAD | ICAD INC | Jan 10, 2022 | 1 | $0 | 4/A | Jan 18, 2022 | CHIEF FINANCIAL OFFICER |
| ICAD | ICAD INC | Dec 8, 2021 | 1 | $49.4K | 4 | Dec 15, 2021 | CHIEF FINANCIAL OFFICER |
| ICAD | ICAD INC | Aug 2, 2021 | 1 | $0 | 4 | Aug 4, 2021 | Chief Financial Officer |